Gerresheimer AG (ETR:GXI – Get Free Report) was up 0.9% on Wednesday . The company traded as high as €69.45 ($71.60) and last traded at €69.45 ($71.60). Approximately 202,264 shares were traded during mid-day trading, an increase of 44% from the average daily volume of 140,925 shares. The stock had previously closed at €68.85 ($70.98).
Gerresheimer Trading Up 0.9 %
The stock has a market cap of $2.40 billion, a PE ratio of 20.92, a PEG ratio of 0.82 and a beta of 0.94. The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36. The firm has a fifty day simple moving average of €74.44 and a two-hundred day simple moving average of €88.14.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Further Reading
- Five stocks we like better than Gerresheimer
- Stock Market Sectors: What Are They and How Many Are There?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Do ETFs Pay Dividends? What You Need to Know
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.